Tamara Elmore

  • Chemistry and Life Sciences
  • Patent Attorney , Senior associate
  • Amersfoort (NL)
  • +31 33 422 73 00
  • t.elmore@vo.eu
  • "Patents can work for or against you. Creating your own patent portfolio, while mitigating the risks of your competitors’ IP rights, is essential for success in today’s technology-based economy"
    • Biography

    • Tamara Elmore is a Dutch and European patent attorney and a United States patent agent. She started her career at a large pharmaceutical company in Switzerland, before joining an IP office in Boston as a US patent agent. In 2009, she switched to V.O. where she is active as a patent attorney in the Chemistry & Life Sciences Department.

      One of her goals is to provide clients with the information and analysis that will enable them to make informed business decisions over complex intellectual property matters.

      Tamara's focus is on obtaining patent protection for her clients’ inventions and strategically managing their patent portfolios. Additional aspects of her practice include patent validity and infringement analysis as well as IP due diligence.   

    • Working experience

    • Patent Attorney, V.O. (2009-present)
    • United States Patent Agent, Ropes & Gray (2006-2009)
    • European Patent Attorney trainee, Hoffman La-Roche (2005)
    • Post-doc, University of Zurich (2002 - 2004)
    • Education

    • Master in Intellectual Property, ETH, Zurich (2005)
    • PhD in Molecular Biology, University of Texas Southwestern (2002)
    • MSc in Zoology, Texas Tech University (1995)
    • Qualifications

    • European Patent Attorney
    • Dutch Patent Attorney
    • United States Patent Agent
    • Specializations

    • Biochemistry
    • Biology
    • Biomarkers
    • Biomedical technology
    • Cell biology and genetics
    • Health products
    • IP due diligence
    • Life Science
    • Lifecycle management
    • Medical diagnostics
    • Medical foods
    • Medical sciences
    • Medicine
    • Medicines
    • Microbiology
    • Pharmaceuticals
    • Vaccines
    • Publications

    • Elmore T, Reach-through royalty provisions in licensing contracts; The Berkeley Electronic Press (bepress) 2005 http://www.bepress.com/ndsip/reports/art2
    • Elmore T, Ignell R, Carlson JR, Smith DP. Targeted mutation of a Drosophila odor receptor defines receptor requirement in a novel class of sensillum. J Neurosci. 2003 Oct 29;23(30):9906-12.
    • Elmore T, Smith DP. Putative Drosophila odor receptor OR43b localizes to dendrites of olfactory neurons. Insect Biochem Mol Biol. 2001 Jun 22;31(8):791-8.
    • Elmore T, Rodriguez A, Smith DP. dRGS7 encodes a Drosophila homolog of EGL-10 and vertebrate RGS7. DNA Cell Biol. 1998 Nov;17(11):983-9.
    • Languages

    • English